Cardionyx Heart Science Israeli Company
Cardionyx is developing an active implant to stimulate baroreceptors for Heart Failure (HF) patients, through a minimally invasive approach. Cardionyx stands at the forefront of medical innovation, poised to address the critical clinical needs of Heart Failure (HF) patients with reduced ejection fraction (HFrEF) through its groundbreaking approach.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Tel Aviv, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/cardionyx-heart-science
External links are provided for reference and verification purposes.